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A B S T R A C T
Background
Osteoarthritis is the most common form of joint disorder and a leading cause of pain and physical disability. Observational studies
suggested a benefit for joint lavage, but recent, sham-controlled trials yielded conflicting results, suggesting joint lavage not to be
effective.
Objectives
To compare joint lavage with sham intervention, placebo or non-intervention control in terms of effects on pain, function and safety
outcomes in patients with knee osteoarthritis.
Search strategy
We searched CENTRAL, MEDLINE, EMBASE, and CINAHL up to 3 August 2009, checked conference proceedings, reference lists,
and contacted authors.
Selection criteria
We included studies if they were randomised or quasi-randomised trials that compared arthroscopic and non-arthroscopic joint lavage
with a control intervention in patients with osteoarthritis of the knee. We did not apply any language restrictions.
Data collection and analysis
Two independent review authors extracted data using standardised forms. We contacted investigators to obtain missing outcome
information. We calculated standardised mean differences (SMDs) for pain and function, and risk ratios for safety outcomes. We
combined trials using inverse-variance random-effects meta-analysis.
Main results
We included seven trials with 567 patients. Three trials examined arthroscopic joint lavage, two non-arthroscopic joint lavage and
two tidal irrigation. The methodological quality and the quality of reporting was poor and we identified a moderate to large degree of
heterogeneity among the trials (I2 = 65%). We found little evidence for a benefit of joint lavage in terms of pain relief at three months
(SMD -0.11, 95% CI -0.42 to 0.21), corresponding to a difference in pain scores between joint lavage and control of 0.3 cm on a
10-cm visual analogue scale (VAS). Results for improvement in function at three months were similar (SMD -0.10, 95% CI -0.30 to
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0.11), corresponding to a difference in function scores between joint lavage and control of 0.2 cm on a WOMAC disability sub-scale
from 0 to 10. For pain, estimates of effect sizes varied to some degree depending on the type of lavage, but this variation was likely
to be explained by differences in the credibility of control interventions: trials using sham interventions to closely mimic the process
of joint lavage showed a null-effect. Reporting on adverse events and drop out rates was unsatisfactory, and we were unable to draw
conclusions for these secondary outcomes.
Authors’ conclusions
Joint lavage does not result in a relevant benefit for patients with knee osteoarthritis in terms of pain relief or improvement of function.
P L A I N L A N G U A G E S U M M A R Y
Joint lavage for osteoarthritis of the knee
This summary of a Cochrane review presents what we know from research about the effect of joint lavage for osteoarthritis (OA) of
the knee. The review shows that in people with OA, joint lavage;
- may not improve pain and function compared to a sham treatment or no treatment.
We often do not have precise information about side effects and complications. This is particularly true for rare but serious side effects.
What is osteoarthritis and what is joint lavage
Osteoarthritis (OA) is the most common form of arthritis that can affect the hands, hips, and knees. In OA, the cartilage breaks down
and may cause swelling and consecutive pain. OA can occur in different areas of the knee or the whole knee. When the cartilage breaks
down, bits of tissue are left around the knee joint, which can add to the inflammation and prevent the joint from working properly.
Joint lavage means to wash out any loose tissue or debris from inside the joint space. It involves temporally inserting small tubes into
1 or more entry points into the knee.
This systematic review discusses three types of joint lavage. Tidal irrigation joint lavage uses only one entry point to alternately inject
fluid, and then draw it out. Non-arthroscopic joint lavage uses two entry points, one to inject the fluid and a separate one for the
withdrawal of the fluid, but no visual inspection of the knee is performed. Arthroscopic joint lavage is a formal joint lavage in addition
to a visually inspection of the knee joints structures as this is done.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Joint lavage compared with sham intervention, placebo injection or no control intervention for patients with osteoarthritis of the knee
Patient or population: Patients with osteoarthritis of the knee
Settings: Outpatient clinic of either rheumatologic, orthopedic or veteran’s hospital departments
Intervention: Arthroscopic or non-arthroscopic joint lavage or tidal irrigation
Comparison: Sham intervention, placebo injections or no control intervention
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Sham or no intervention Joint lavage
Pain intensity
Various validated pain
scales
Follow up: 3 months after
intervention
-1.8 cm change
on 10 cm VAS1
29% improvement
-2.1 cm change
(1 -0.3 cm, -1.1 to
0.5cm)2
34% improvement
(1 +5%, -8% to +18%)
3
SMD -0.11 (-0.42 to
0.21)
567
(7 studies)
++OO6
low
Little evidence of benefi-
cial effect [NNT: not sta-
tistically significant]
Pain intensity
Various validated pain
scales
Follow up: 1 year after
intervention
-1.8 cm change
on 10 cm VAS1
29% improvement
-2.1 cm change
(1 -0.3 cm, -1.3 to 0.7
cm)2
34% improvement
(1+5%, -11% to+21%)
3
SMD -0.10 (-0.50 to
0.29)
380
(3 studies)
++OO6
low
Little evidence of benefi-
cial effect [NNT: not sta-
tistically significant]
Function
Various validated function
scales.
Follow up: 3 months after
intervention
-1.2 units on WOMAC
(range 0 to 10)1
21% improvement
-1.4 units on WOMAC
(1 -0.2, -0.6 to +0.2)4
26% improvement
(1 +5%, -3% to +12%)
5
SMD -0.10 (-0.30 to
0.11)
540
(5 studies)
++OO6
low
Little evidence of benefi-
cial effect [NNT: not sta-
tistically significant]
3
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Function
Various validated function
scales.
Follow up: 1 year after
intervention
-1.2 units on WOMAC
(range 0 to 10)1
21% improvement
-1.6 units on WOMAC
(1 -0.4, -0.8 to 0.0)4
28% improvement
(1 +7%, +0% to
+15%)5
SMD -0.17 (-0.38 to
0.03)
381
(3 studies)
++OO6
low
Little evidence of benefi-
cial effect [NNT: not sta-
tistically significant]
Number of patients
experiencing adverse
events
Follow up: up to 1 year
after intervention
See comment See comment Not estimable 0
(0 study)
See comment 0 trials provided data for
this outcome
Number of patients who
withdrew due to adverse
event
Follow up: up to 1 year
after intervention
150 per 1000 patient-
years1
Not estimable Not estimable 8
(1 study)
+OOO7
very low
NNH not estimable
Number of patients ex-
periencing any serious
adverse event
Follow up: up to 1 year
after intervention
4 per 1000 patient-years
1
Not estimable Not estimable 98
(1 study)
+OOO7
very low
1 serious adverse event
reported. NNH not es-
timable
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; SMD: Standardised mean difference; GRADE: GRADE Working Group grades of evidence (see explanations); OA: osteoarthritis; SD: standard deviation; SMD:
standardised mean difference; NNT: number needed to treat; NNH: number needed to harm; VAS: visual analogue scale
GRADE Working Group grades of evidence
High quality (++++): Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality (+++O): Further research is likely to have an important impact on our confidence in the estimate of effect and may
change the estimate.
Low quality (++OO): Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely
to change the estimate.
Very low quality (+OOO): We are very uncertain about the estimate.
1 Median reduction as observed across control groups in large OA trials (Nuesch 2009).4
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2 SMDs were back-transformed onto a 10 cm VAS on the basis of a typical pooled SD of 2.5 cm in trials that assessed pain using a
VAS, and expressed as change based on an assumed standardised reduction of 0.72 standard deviation units in the control group.
3 The median observed pain score at baseline across control groups in large OA trials was 6.1 cm on a 10-cm VAS (Nuesch 2009).
4 SMDs were back-transformed onto a 0 to 10 standardised WOMAC function score on the basis of a typical pooled SD of 2.1 in
trials that assessed function on WOMAC function scale and expressed as change based on an assumed standardised reduction of 0.58
standard deviation units in the control group.
5 The median observed standardised WOMAC function score at baseline across control groups in large OA trials was 5.6 units (Nuesch
2009).
6 Downgraded (2 levels) because number of randomised patients per trial and the number of patients overall were low, the confidence
interval is wide, 4 out of 7 trials reported unclear of concealment of allocation methods, and only 2 trials reported analysis according to
intention-to-treat principle.
7 Downgraded (3 levels) because inadequate reporting of secondary outcomes.
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B A C K G R O U N D
Osteoarthritis (OA) is the most common form of joint disease
and the leading cause of pain and physical disability in the elderly
(Altman 1996). It is characterised by focal areas of loss of articular
cartilage in synovial joints, accompanied by subchondral bone
changes, osteophyte formation at the joint margins, thickening
of the joint capsule, and mild synovitis. Symptoms include pain,
stiffness, and decreased range of motion, limiting daily activities
and quality of life.
To manage symptoms of OA, patients and healthcare providers
often resort to multiple approaches, including lifestyle modifica-
tions, medications such as non-steroidal anti-inflammatory drugs,
and physical therapy. When conservative therapy fails to relieve
pain, surgery is often recommended. A variety of invasive interven-
tions have been described, including non-arthroscopic and arthro-
scopic lavage, arthroscopic debridement, corrective osteotomy,
and total knee replacement. Non-arthroscopic and arthroscopic
lavage are widely used techniques, consisting of rinsing out the
knee with up to 10 litres of fluid. Any intra-articular debris, such as
micro- or macroscopic cartilage fragments or calcium phosphate
crystals which may cause pain or inflammation, were suggested to
be flushed out through cannulas (Bradley 2003).
Joint lavage can be technically grouped into three different cate-
gories, according to whether a visual inspection of the knee joint
was performed and, in the absence of visual inspection, according
to the number of entry sites. In this systematic review we will use
the following terms to denominate these categories.
1. Tidal irrigation joint lavage: uses only one entry site for the
sequential instillation and withdrawal of the irrigation fluid.
2. Non-arthroscopic joint lavage: two entry sites are used, one for
the instillation of the irrigation fluid and one for the withdrawal,
but no visual inspection of the knee is performed.
3. Arthroscopic joint lavage: in addition to an arthroscopy of the
knee joint, a formal joint lavage is performed. In contrast to arthro-
scopic debridement, no instruments are used to mechanically de-
bride or remove intraarticular tissue.
In a retrospective case series of arthroscopic lavage (Jackson 2003),
more than 50% of patients reported significant relief of symptoms
lasting between one and five years. The procedure was most effec-
tive when performed during the earlier stages of the degenerative
process. An early study comparing lavage and physiotherapy with
physiotherapy alone, showed clearly better pain relief in the lavage
group, with effects again lasting for up to one year (Livesley 1991).
However, results fromone randomised controlled trial (RCT) sug-
gested that arthroscopic lavage may not be effective compared to
a sham intervention (Moseley 2002).
O B J E C T I V E S
We set out to compare joint lavage with a sham intervention,
placebo injections, or a non-intervention control in terms of effects
on pain, function, and safety in patients with knee OA.
M E T H O D S
Criteria for considering studies for this review
Types of studies
RCTs or quasi RCTs with a control group receiving a sham inter-
vention to closely mimic the process of joint lavage, placebo injec-
tions, or a non-intervention control. We considered trials using an
unpredictable allocation sequence as randomised; we considered
trials using potentially predictable allocation mechanisms, such as
alternation or the allocation of patients according to date of birth,
as quasi-randomised.
Types of participants
We included patients with osteoarthritis of the knee. We did not
consider trials including exclusively patients with inflammatory
arthritis, such as rheumatoid arthritis.
Types of interventions
Arthroscopic and non-arthroscopic, but not open lavage. We ex-
cluded arthroscopic debridement, which is covered in a separate
Cochrane Review (Laupattarakasem 2008).
Types of outcome measures
Main outcomes were pain and function, as currently recom-
mended for osteoarthritis trials (Altman 1996; Pham 2004). If
data on more than one pain scale were provided for a trial, we
referred to a previously described hierarchy of pain-related out-
comes (Juni 2006; Reichenbach 2007) and extracted data on the
pain scale that was highest on this list:
1. Global pain
2. Pain on walking
3. WOMAC osteoarthritis index pain sub score
4. Composite pain scores other than WOMAC
5. Pain on activities other than walking
6. Rest pain or pain during the night
7. WOMAC global algofunctional score
8. Lequesne osteoarthritis index global score
9. Other algofunctional scale
10. Patient’s global assessment
11. Physician’s global assessment
If data on more than one function scale were provided for a trial,
we extracted data according to the hierarchy presented below.
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1. Global disability score
2. Walking disability
3. WOMAC disability sub score
4. Composite disability scores other than WOMAC
5. Disability other than walking
6. WOMAC global scale
7. Lequesne osteoarthritis index global score
8. Other algofunctional scale
9. Patient’s global assessment
10. Physician’s global assessment
If pain or function outcomes were reported at several time points,
we extracted the measure at three months as the main outcome.
As a secondary time point, we extracted pain and function data
one year after the intervention, if available.
Secondary outcomes
Secondary outcomes were the number of patients experiencing
any adverse event, patients who were withdrawn or dropped out
because of adverse events, and patients experiencing any serious
adverse events. Serious adverse events were defined as events result-
ing in in-patient hospitalisation, prolongation of hospitalisation,
persistent or significant disability, congenital abnormality or birth
defect of offspring, life-threatening events, or death.
Search methods for identification of studies
Electronic searches
We searched electronic databases of CENTRAL through The
Cochrane Library (http://mrw.interscience.wiley.com/cochrane/
), MEDLINE and EMBASE through the Ovid platform
(www.ovid.com), CINAHL through EBSCOhost, all from imple-
mentation to August 03, 2009 using a combination of keywords
and text words related to lavage combined with keywords and text
words related to osteoarthritis and a validated filter for controlled
clinical trials (Dickersin 1994).We have presented the search strat-
egy in Appendix 1 and Appendix 2.
Searching other resources
We manually searched conference proceedings, used Science Ci-
tation Index to retrieve reports citing relevant articles, contacted
content experts and trialists and screened reference lists of all ob-
tained articles, including related reviews. Finally, we searched sev-
eral clinical trial registries (www.clinicaltrials.gov, www.controlled-
trials.com, www.actr.org.au, www.umin.ac.jp/ctr) to identify on-
going trials. The last update of the manual search was on August
31, 2009.
Data collection and analysis
Selection of studies
Two review authors independently evaluated all titles and abstracts
for eligibility. We resolved disagreements by discussion. We did
not apply any language restrictions. If multiple reports described
the same trial, we considered all.
Data extraction and management
Two review authors (SR and AR) extracted trial information in-
dependently using a standardised, piloted data extraction form
accompanied by a codebook. We resolved disagreements by con-
sensus or discussion with a third author. We extracted the exact
technique of the experimental intervention, the type of control,
the amount of lavage fluid, patient characteristics (average age,
gender, mean duration of symptoms), type of pain- or function-
related outcome, trial design, trial size, duration of follow up, type
and source of financial support and publication status. When nec-
essary, we approximated means and measures of dispersion from
figures in the reports. For cross-over trials, we extracted data from
the first period only, because of possible carry-over effects. When-
ever possible, we used results from an intention-to-treat analysis.
If we could not calculate effect sizes, we contacted the authors for
additional data.
Assessment of risk of bias in included studies
Two review authors (SR and AR) independently assessed randomi-
sation, blinding, and adequacy of analyses (Juni 2001). We re-
solved disagreements by consensus. We assessed two components
of randomisation: generation of allocation sequences and con-
cealment of allocation. We considered the generation adequate
if it resulted in unpredictable allocation sequences; mechanisms
considered adequate included random-number tables, computer-
generated random numbers, minimisation, coin tossing, shuffling
of cards, and drawing of lots. We considered allocation conceal-
ment adequate if the investigators responsible for patient selection
were unable to deduce before allocation which treatment was next;
methods considered adequate included central randomisation and
sequentially numbered, sealed, opaque envelopes. We considered
blinding of the patients adequate if the interventions were explic-
itly described as indistinguishable. We therefore considered sham
interventions used to closely mimic the process of joint lavage ad-
equate, but not mere placebo injections. We considered analyses
adequate if all randomised patients were included in the analy-
sis according to the intention-to-treat principle. In addition, we
extracted the source of funding and distinguished between non-
profit and commercial funding bodies. Finally, we used GRADE
to describe the quality of the overall body of evidence (Guyatt
2008; Higgins 2008), defined as the extent of confidence into the
estimates of treatment benefits and harms.
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Data synthesis
We summarised continuous outcomes using standardised mean
differences (SMD), with the differences in mean values at three
months andone year after the intervention across treatment groups
divided by the pooled standard deviation. An SMD of -0.20 stan-
dard deviation units can be considered a small difference between
experimental and control group, an SMD of -0.50 a moderate,
and -0.80 a large difference (Cohen 1988; Juni 2006). SMDs can
be interpreted in terms of the percentage overlap of the experi-
mental group’s scores with scores of the control group. An SMDof
-0.20 indicates an overlap in the distributions of pain or function
scores in about 85% of cases, an SMD of -0.50 in approximately
67%, and an SMD of -0.80 in about 50% of cases (Cohen 1988;
Juni 2006). On the basis of a median pooled SD of 2.5 cm found
in large-scale osteoarthritis trials that assessed pain using a 10 cm
visual analogue scale (VAS) (Nuesch 2009), SMDs of -0.20, -0.50
and -0.80 correspond to approximate differences in pain scores
between experimental and control groups of 0.5, 1.25, and 2.0
cm on a 10 cm VAS. We back transformed SMDs for function to
a standardised WOMAC disability score (Bellamy 1995) ranging
from 0 to 10 on the basis of a median pooled SD of 2.1 units ob-
served in large-scale osteoarthritis (Nuesch 2009). We expressed
binary outcomes as relative risks.
We used standard inverse-variance random-effects meta-analysis
to combine the trials (DerSimonian 1986). We quantified het-
erogeneity between trials using the I2 statistic (Higgins 2003),
which describes the percentage of variation across trials that is at-
tributable to heterogeneity rather than to chance and the corre-
sponding χ2 test. I2 values of 25%, 50% and 75% may be in-
terpreted as low, moderate, and high between-trial heterogeneity,
although the interpretation of I2 depends on the size and num-
ber of trials included (Rucker 2008).The association between trial
size and treatment effects was investigated in funnel plots, plot-
ting effect sizes on the vertical axis against their standard errors
on the horizontal axis. We assessed asymmetry by the asymmetry
coefficient: the difference in effect size per unit increase in stan-
dard error (Sterne 2001), which is mainly a surrogate for sample
size. We performed analyses of the main outcome stratified by the
following trial characteristics: type of intervention (arthroscopic
versus non-arthroscopic lavage); type of control (placebo or sham
intervention versus no intervention); concealment of allocation
(adequate versus inadequate or unclear); blinding of patients (ad-
equate versus inadequate or unclear); analysis in accordance with
the intention-to-treat principle (yes versus no or unclear); trial
size; funding; length of follow up, and differences in the use of
co-interventions in the trial groups. A cut-off of 200 allocated pa-
tients was used to distinguish between small-scale and large-scale
trials.We used univariable random-effects meta-regression models
(Thompson 1999) to determine whether treatment effects were
affected by these factors. In addition, we included the amount of
lavage fluid used as a continuous variable at the trial level in a
uni-variable meta-regression. Then, we converted SMDs of pain
intensity and function to odds ratios (Chinn 2000) and derived
numbers needed to treat (NNT) to cause one additional treat-
ment response on pain or function as compared with control, and
numbers needed to harm (NNH) to cause one additional adverse
outcome. We defined treatment response as a 50% improvement
in scores (Clegg 2006), which corresponds to an average decrease
of 1.2 standard deviation units. Based on the median standardised
pain intensity at baseline of 2.4 standard deviation units and the
median standardised decrease in pain scores of 0.72 standard de-
viation units observed in large osteoarthritis trials (Nuesch 2009),
we calculated that a median of 31% of patients in the control
group would achieve an improvement of pain scores of 50% or
more. This percentage was used as the control group response rate
to calculate NNTs for treatment response on pain. Based on the
median standardised WOMAC function score at baseline of 2.7
standard deviation units and the median standardised decrease in
function scores of 0.58 standard deviation units (Nuesch 2009),
26% of patients in the control group would achieve a reduction
in function of 50% or more. Again, this percentage was used as
the control group response rate to calculate NNTs for treatment
response on function. Median risks of 150 patients with adverse
events per 1000 patient-years, four patients with serious adverse
events per 1000 patient-years and 17 dropouts due to adverse
events per 1000 patient-years observed in placebo groups in large
osteoarthritis trials (Nuesch 2009) were used to calculate NNHs
for safety outcomes. All P values are two-sided. We performed the
data analysis in Review Manager version 5 (RevMan 2008) and
STATA version 10.1 (STATA 2008).
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
We identified 2073 potentially relevant references through our
electronic searches (Figure 1) and considered 22 to be potentially
eligible. We found two additional references through searches of
conferences proceedings and abstracts. One trial would be eligible,
but is ongoing (ISRCTN82192623, seeCharacteristics of ongoing
studies). Seven RCTs met our inclusion criteria. We found three
trials that performed joint lavage arthroscopically (Moseley 1996;
Kalunian 2000;Moseley 2002). In two trials, joint lavage was per-
formed without arthroscopy (Dawes 1987; Ravaud 1999). Tidal
irrigation was performed in two trials (Ike 1992; Bradley 2002).
Of the completed trials, six trials used a parallel group and one a
2 x 2 factorial design (Ravaud 1999), assigning 50% of the par-
ticipants to intra-articular corticosteroid injections.
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Figure 1. Study flow chart
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Four trials used a formal sham intervention to closely mimic the
process of joint lavage (Moseley 1996; Kalunian 2000; Bradley
2002; Moseley 2002). Moseley 1996, Bradley 2002, and Moseley
2002 used sham procedures, two with incisions but without ad-
vancing instrument or applying intra-articular fluids (Moseley
1996; Moseley 2002 ), one with incisions, advancing the instru-
ments to the joint capsule without perforating it (Bradley 2002)
and one with incisions, advancing the instruments through the
joint capsule and application of a small amount of intraarticular
irrigation fluid of 250ml (Kalunian 2000). Two trials used placebo
saline injections (Dawes 1987; Ravaud 1999), and one trial used a
non-intervention control receiving standard conservative care (Ike
1992). In all trials, joint lavage and control intervention were per-
formed only once, but different amounts of irrigation fluid were
used, ranging from 1,000 ml (Ike 1992; Ravaud 1999; Bradley
2002) to 10,000 ml (Moseley 1996; Moseley 2002).
The median follow-up duration was six months, ranging from
three months to two years. All trials provided results for our main
time point of assessment at three months. Three trials had a long
follow-up duration of at least one year (Kalunian 2000; Bradley
2002; Moseley 2002). The median average age of included pa-
tients was 59.5 years (range 46 to 67), and the median percentage
of females was 56% (range 0% to 69%). The mean duration of
symptoms was reported in three trials and ranged from 2.7 to 10.6
years.
Risk of bias in included studies
Figure 2 summarises the methodological characteristics and
sources of funding of included trials. None of the trials reported
both adequate sequence generation and allocation concealment.
Two trials reported adequate sequence of generation (Ravaud
1999; Kalunian 2000), and three trials reported adequate alloca-
tion concealment (Moseley 1996; Bradley 2002; Moseley 2002).
In other trials the method of patient allocation remained unclear.
Four trials were described as double blind, using a sham interven-
tion to blind the patients (Moseley 1996; Kalunian 2000; Bradley
2002; Moseley 2002). In the other trials, blinding of patients was
questionable because placebo injections were used as described
above, which were distinguishable from experimental interven-
tions (Dawes 1987; Ravaud 1999), and in one trial no attempt
was made to blind patients (Ike 1992). Blinding of physicians was
not deemed possible. Two trials analysed pain and function out-
come according to the intention-to-treat principle (Ravaud 1999;
Bradley 2002). Two trials did not report the number of patients
excluded from the analysis (Dawes 1987; Kalunian 2000). In the
remaining three trials (Ike 1992; Moseley 1996; Moseley 2002),
exclusions of patients ranged from 3.3% to 33.3% in experimen-
tal and from 6.7% to 26.3% in control groups. None of the trials
reached our prespecified cut-off of 200 allocated patients to dis-
tinguish between small- and large-scale trials.
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Figure 2. Methodological characteristics and source of funding of included trials. (+) indicates low risk of
bias, (?) unclear and (-) a high risk of bias on a specific item.
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Five trials reported a primary outcome (Ike 1992; Ravaud 1999;
Kalunian 2000; Bradley 2002;Moseley 2002). None of these trials
explicitly reported the primary outcome to be prespecified in the
protocol. Four trials reported a sample size calculation for this pri-
mary outcome (Ike 1992; Kalunian 2000; Bradley 2002; Moseley
2002). Two trials reported financial support by both commercial
and non-profit organisations (Ravaud 1999; Kalunian 2000). Two
trials reported financial support by non-commercial organisations
only (Bradley 2002; Moseley 2002), and one trial reported finan-
cial support by a commercial body only (Ike 1992).
For the effectiveness outcomes, pain, and function, the quality of
the evidence (Guyatt 2008) was classified as low in view of the
high risk of bias in the included trials and the high heterogeneity
between trials (Summary of findings for the main comparison).
For adverse event and serious adverse event outcomes, the quality
of the evidence (Guyatt 2008) was classified as very low because of
the small number of trials reporting the outcomes and the small
number of serious adverse events whichmade estimates impossible
(Summary of findings for the main comparison).
Effects of interventions
See: Summary of findings for the main comparison
Primary outcomes
Knee pain
Seven trials including 275 patients in experimental groups and
292 patients in control groups contributed to the analyses of knee
pain. Figure 3 presents results of the analysis, overall and stratified
according to the type of lavage. In the overall analysis, joint lavage
was not more effective in pain reduction than control interven-
tions (SMD -0.11, 95% CI -0.42 to 0.21). This corresponds to
a difference in pain scores of 0.3 cm on a 10 cm VAS between
joint lavage and control intervention, and to a difference in im-
provement from baseline of 5% (95% CI -8% to 18%), respec-
tively (Summary of findings for the main comparison). An I2 of
65% indicated a moderate to large degree of between-trial het-
erogeneity (P for heterogeneity = 0.009). A visual inspection of
the funnel plot suggested some degree of asymmetry, with smaller,
more imprecise trials showing less beneficial results than larger tri-
als (asymmetry coefficient 1.43, 95% CI -1.68 to 4.54), but the
test for asymmetry provided little evidence for asymmetry (P =
0.57) (Figure 4).
Figure 3. Forest plot of 7 trials comparing the effects of any type of joint lavage and control interventions
on knee pain after 3 months. Values on x-axis denote standardised mean differences (SMDs). The plot is
stratified according to type of joint lavage.
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Figure 4. Funnel plot for effects on knee pain.
Numbers on x-axis refer to SMDs, on y-axis to standard errors of SMDs.
Figure 3 and Table 1 indicate that estimates of effect sizes varied
to some degree depending on the type of lavage. The largest effect
size was found in tidal irrigation (SMD -0.36, 95% CI -0.78 to
0.07; 2 trials), followed by non-arthroscopic joint lavage with a
small effect size (SMD -0.15, 95% CI -1.19 to 0.90; 2 trials), and
arthroscopic joint lavage with a trend towards a small harmful ef-
fect (SMD 0.21, 95% CI -0.06 to 0.48; 3 trials). The confidence
intervals were wide, however, and a test for interaction between
benefit and type of lavage was non-significant (P = 0.27). In the
additional stratified analyses presented in Table 1, we found some
evidence that the effect size decreases with an increase of the extent
and credibility of patient blinding. Figure 5 graphically displays
this analysis. There appeared to be a linear trend, with trials with
a credible sham intervention showing a null effect of joint lavage
(SMD 0.06, 95%CI -0.21 to 0.32), trials with a placebo injection
showing a small benefit on average (SMD -0.14, 95% CI -1.19
to 0.91), and the trial with a non-intervention control showing a
moderate to large benefit (SMD -0.64. 95% CI -1.17 to -0.11).
The P value for trend between extent of credibility of the control
intervention and treatment benefit was 0.09. We found little ev-
idence for an association of SMDs with allocation concealment,
blinding of patients, intention-to-treat analysis, funding by non-
commercial body, and use of analgesic co-interventions. None of
the trials had a sample size above 200 patients; therefore we could
not assess the impact of this characteristic on estimated treatment
effects. In an additional uni-variable meta-regression analysis, we
did not find an association between the amount of lavage fluid
used and effect size (decrease in benefit per 1000 ml increase in
volume of 0.07 SMDs, 95% CI -0.03 to 0.17, P = 0.13).
13Joint lavage for osteoarthritis of the knee (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 5. Forest plot of 7 trials comparing the effects of any type of joint lavage and control interventions on
knee pain after 3 month, stratified according to type of control interventions. Values on x-axis denote SMDs.
Table 1. Stratified analysis: pain
Variable Number of
comparisons
Number of pa-
tients in experi-
mental group
Number of pa-
tients in control
group
Pain intensity Heterogeneity P-value for inter-
action
n n n SMD (95% CI) I2 (%)
Overall 7 275 292 -0.11 (-0.42 to
0.21)
65%
Type of joint
lavage
0.27
Arthroscopic
joint lavage
3 102 110 0.21 (-0.06 to
0.48)
0%
Non-arthro-
scopic joint
lavage
2 55 63 -0.15 (-1.19 to
0.90)
78%
Tidal irrigation 2 118 119 -0.36 (-0.78 to
0.07)
52%
Type of control
intervention
0.09*
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Table 1. Stratified analysis: pain (Continued)
Sham interven-
tion
4 191 201 0.06 (-0.21 to
0.32)
32%
Placebo injec-
tion
2 55 63 -0.15 (-1.19 to
0.90)
78%
No control in-
tervention
1 29 28 -0.64 (-1.17 to -
0.10)
N/A
Allocation con-
cealment
0.46
Adequate 3 150 152 0.03 (-0.34 to
0.40)
46%
Inadequate or
unclear
4 125 140 -0.21 (-0.72 to
0.31)
74%
Blinding of pa-
tients
0.11
Adequate 4 191 201 0.06 (-0.21 to
0.32)
32%
Inadequate or
unclear
3 84 91 -0.38 (-0.91 to
0.15)
61%
Intention-to-
treat analysis
0.21
Yes 2 134 144 -0.37 (-0.78 to
0.03)
63%
No 5 141 148 0.07 (-0.33 to
0.47)
56%
Number
of patients ran-
domised
N/A
> 200 0 N/A
< 200 7 275 292 -0.11 (-0.42 to
0.21)
65%
Funding by non-
commercial
body avoided
0.46
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Table 1. Stratified analysis: pain (Continued)
Yes 3 150 152 0.03 (-0.34 to
0.40)
46%
No or unclear 4 125 140 -0.21 (-0.72 to
0.31)
74%
Use of analgesic
co-interventions
0.12
Yes 4 222 228 -0.28 (-0.65 to
0.09)
73%
No or unclear 3 53 64 0.26 (-0.11 to
0.63)
0%
CI: confidence interval
* P value for trend
SMD: standardised mean difference
Three trials that included 187 patients in experimental groups and
193 patients in control groups contributed to the analyses of pain
one year after the intervention (Kalunian 2000; Bradley 2002;
Moseley 2002). All three trials used a sham procedure as their
control intervention. We found little evidence for a pain reduction
as compared with sham intervention (SMD -0.10, 95% CI -0.50
to 0.29, P = 0.60, Figure 6), but between-trial heterogeneity was
large (I2 = 72%).
Figure 6. Forest plot of 3 trials comparing the effects of any type of lavage and control interventions on
knee pain after one year. Values on x-axis denote SMDs.
Function
Five trials including 263 patients in experimental groups and 272
patients in control groups contributed to the analyses of physi-
cal function. Figure 7 presents results of the analysis, overall and
stratified according to the type of lavage. In the overall analysis,
joint lavage showed no improvement in function compared to
control interventions (SMD -0.10, 95% CI -0.30 to 0.11). This
corresponds to a difference in function scores of 0.4 units between
joint lavage and control interventions on a standardisedWOMAC
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disability scale ranging from 0 to 10, and to a difference in im-
provement from baseline of 7% (95% CI 0% to 15%), respec-
tively (Summary of findings for the main comparison). An I2 of
28% indicated a small degree of between-trial heterogeneity (P for
heterogeneity = 0.24). A visual inspection of the funnel plot sug-
gested little asymmetry, with smaller, more imprecise trials show-
ing less beneficial results than larger trials (asymmetry coefficient
3.19 (95% CI -5.98 to 12.37), but the test for asymmetry pro-
vided little evidence for asymmetry (P = 0.37) (Figure 8).
Figure 7. Forest plot of 5 trials comparing the effects of any type of joint lavage and control interventions on
function after 3 month. Values on x-axis denote SMDs. The plot is stratified according to type of joint lavage. .
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Figure 8. Funnel plot for effects on knee function.
Numbers on x-axis refer to SMDs, on y-axis to standard errors of SMDs.
Figure 7 and Table 2 indicate that estimates of effect sizes varied to
some degree depending on the type of lavage. The largest effect size
was found in non-arthroscopic joint lavage (SMD -0.43, 95%CI -
0.84 to -0.02; 1 trial). Arthroscopic joint lavage and tidal irrigation
showed no benefit, with effect sizes of 0.01 for arthroscopic joint
lavage (95%CI -0.26 to 0.29; 2 trials) and -0.04 for tidal irrigation
(95% CI -0.43 to 0.35; 2 trials). The confidence intervals were
wide and a test for interactionbetween type of lavage and treatment
benefit negative (P = 0.43). Table 2 presents additional results
from stratified analyses, with some degree of variation of effect
sizes across strata, but negative tests for interaction throughout.
As for pain, we did not find an association between the amount
of lavage fluid used and effect size in an additional uni-variable
meta-regression analysis (decrease in benefit per 1000 ml increase
in volume of 0.01 SMDs, 95% CI -0.10 to 0.12, P = 0.81).
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Table 2. Stratified analysis: function
Variable Number of
comparisons
Number of pa-
tients in experi-
mental group
Number of pa-
tients in control
group
Function Heterogeneity P-value for inter-
action
n n n SMD (95% CI) I2 (%)
Overall 5 263 277 -0.10 (-0.30 to
0.11)
28%
Type of joint
lavage
0.43
Arthroscopic
joint lavage
2 100 105 0.01 (-0.26 to
0.29)
0%
Non-arthro-
scopic joint
lavage
1 45 53 -0.43 (-0.83 to -
0.03)
N/A
Tidal irrigation 2 118 119 -0.04 (-0.44 to
0.36)
48%
Type of control
intervention
0.79*
Sham interven-
tion
3 189 196 -0.08 (-0.28 to
0.12)
0%
Placebo injec-
tion
1 45 53 -0.43 (-0.83 to -
0.03)
N/A
No control in-
tervention
1 29 28 0.23 (-0.29 to
0.75)
N/A
Allocation con-
cealment
0.73
Adequate 2 148 147 -0.15 (-0.38 to
0.08)
0%
Inadequate or
unclear
3 115 130 -0.04 (-0.45 to
0.37)
62%
Blinding of pa-
tients
0.75
Adequate 3 189 196 -0.08 (-0.28 to
0.12)
0%
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Table 2. Stratified analysis: function (Continued)
Inadequate or
unclear
2 74 81 -0.12 (-0.76 to
0.53)
74%
Intention-to-
treat analysis
0.11
Yes 2 134 144 -0.27 (-0.51 to -
0.04)
0%
No 3 129 133 0.06 (-0.18 to
0.30)
0%
Number
of patients ran-
domised
N/A
> 200 0 N/A
< 200 5 263 277 -0.10 (-0.30 to
0.11)
28%
Funding by non-
commercial
body avoided
0.73
Yes 2 148 147 -0.15 (-0.38 to
0.08)
0%
No or unclear 3 115 130 -0.04 (-0.45 to
0.37)
62%
Use of analgesic
co-interventions
0.34
Yes 4 222 228 -0.15 (-0.37 to
0.07)
27%
No or unclear 1 41 49 0.13 (-0.28 to
0.55)
N/A
* P value for trend
Three trials that included 187 patients in experimental groups
and 193 patients in control groups contributed to the analyses
of function one year after intervention (Kalunian 2000; Bradley
2002; Moseley 2002). We found a trend towards more benefit in
experimental groups compared to sham intervention (SMD -0.17,
95% CI -0.38 to 0.03, P = 0.09, Figure 9), with no between-trial
heterogeneity (I2 = 0%).
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Figure 9. Forest plot of 3 trials comparing the effects of any type of lavage and control interventions on
function after one year. Values on x-axis denote SMDs.
Secondary outcomes
The reporting of adverse events and drop-outs due to adverse
events was unsatisfactory. Only one trial (Moseley 1996) reported
one drop out due to an adverse event in the experimental group
because of an acute psychiatric episode of a bipolar disorder. One
trial (Ravaud 1999) reported that no serious adverse events had
occurred.
D I S C U S S I O N
Summary of main results
In our systematic review and meta-analysis of seven small trials,
we found little evidence for a benefit of joint lavage in terms of
pain relief and improvement of function in patients with knee
osteoarthritis three months and one year after the intervention.
For pain, estimates of effect sizes varied to some degree depending
on the type of lavage, but this variation might be explained by
differences in the credibility of control interventions: trials using
sham interventions to closely mimic the process of joint lavage
showed a clear null-effect. For functional improvement, we found
a statistical trend towards a small benefit of lavage one year after
the intervention, which may well be to chance alone.
Reporting on adverse events and drop-out rates was unsatisfac-
tory, and we were not able to draw conclusions for these sec-
ondary outcomes. In view of the potentially serious adverse effects
of an arthroscopy, including joint infection, effusion, hemarthro-
sis, deep vein thrombosis and thus prolonged hospitalisation, ade-
quate reporting of safety outcomes is highly recommended. Since
the accumulated number of serious adverse events may be too low
in RCTs of the size observed in this review, alternative sources of
safety information may be used, including large case series of con-
secutive patients or administrative databases.
Quality of the evidence
The quality of this review is limited by the small numbers of
studies included, the low number of randomly assigned patients
involved and the poor reporting quality. We aimed at including
all possible types of joint lavage compared with all types of control
interventions. The large heterogeneity observed after pooling all
trials could therefore be related to either variation of effects with
the type of lavage or with the type of control intervention. Our
results indicate that the type of control intervention is amore likely
source of variation: trials with credible sham interventions and
adequate blinding of patients showed a null effect and benefits of
the intervention increased with less stringent or lacking blinding
of patients. This is consistent with the findings of a meta-analysis
on determinants of the placebo effect in randomised controlled
trials in osteoarthritis, which found that the pain relief increased
when the placebo was applied invasively (Zhang 2008). A surgical
sham intervention may be considered the most powerful placebo.
Potential biases in the review process
We based our review on a broad literature search. Even though we
cannot exclude potential publication bias, it seems rather unlikely
that we missed relevant trials (Egger 2003). Two review authors
performed selection of trials and data extraction independently
to minimise bias and transcription errors (Gøtzsche 2007; Tendal
2009). The use of different instruments to measure joint pain and
function made it necessary to calculate SMDs as a common mea-
sure of effectiveness to ensure comparability between outcomes
assessed with different instruments. Poor correlation or differences
in responsiveness of different instrumentsmay be a potential threat
to the validity of results (Puhan 2006).
Agreements and disagreements with other
studies or reviews
We are unaware of any systematic review or meta-analysis address-
ing the topic of our review. The most prominent trial included
in our analysis was Moseley 2002. This trial allocated patients
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with knee osteoarthritis to one of three arms, arthroscopic lavage,
arthroscopic debridement or a sham intervention, and found ef-
fects of both interventions to be null or slightly harmful. The trial
was subsequently criticised because of baseline imbalances and its
limited power (Laskin 2005). Our overall results are fully con-
cordant with Moseley 2002’s results however, and - in terms of
the estimated effect of debridement - also recently confirmed by
Kirkley 2008, who compared arthroscopic debridement with a
non-intervention control in 178 patients and found no evidence
of a benefit of debridement.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Joint lavage does not result in a relevant benefit for patients with
knee osteoarthritis in terms of pain relief or improvement of func-
tion. Insufficient numbers of patients have been studied to exclude
the potential for serious adverse events such as joint infection, ef-
fusion, hemarthrosis, or deep vein thrombosis. Joint lavage should
be discouraged in patients with osteoarthritis.
Implications for research
Despite the low number of trials, the relatively small number of
patients randomised, and the low quality of the evidence over-
all, additional trials are difficult to justify. The benefit of joint
lavage is small to minute and likely to be outweighed by safety
concerns. RCTs in orthopedic surgery should be continuously ad-
vocated. The debate is ongoing, however, as to whether invasive
sham interventions are ethically justified and should be seen as a
gold standard for control groups in surgical trials (London 2003;
Miller 2004). Even if invasive sham interventions may be debat-
able, the continued resistance of the orthopaedic field to perform
adequately powered randomised multicenter trials to compare se-
lected surgical interventions with conservative treatment is hard
to justify.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by year of study]
Dawes 1987
Methods Randomised controlled trial
2-arm parallel group design
Trial duration: 12 weeks
No power calculation reported
Funding by non-profit organisation: not reported
Participants 20 patients with knee OA were randomised
Number of females: 12 of 20 (60%)
Average age: 60 years
Average BMI: not reported
Interventions Experimental intervention: non-arthroscopic lavage (volume of irrigation fluid:
2,000ml)
Control intervention: one saline injection
Analgesics allowed
Outcomes Extracted pain outcome: pain on walking after 12 weeks
Extracted function outcome: 25-yards walk time (seconds) after 12 weeks
Primary outcome: not reported
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear No information provided
Allocation concealment? Unclear No information provided
Described as double-blind? No
Blinding of patients? Unclear No information provided
Blinding of physicians? No
Interventions reported as indistinguish-
able?
No
Double-dummy technique used? No
Intention-to-treat analysis (pain)? Unclear No information on exclusions available
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Dawes 1987 (Continued)
Intention-to-treat analysis (function)? Unclear No information on exclusions available
Funding by commercial body avoided? Unclear No information provided
Ike 1992
Methods Randomised controlled trial
2-arm parallel group design
Trial duration: 12 weeks
Multicentre trial with 15 centres
Power calculation reported
Funding by non-profit organisation:not reported
Participants 77 patients with knee OA were randomised
Number of females: 43 of 77 (56%)
Average age: 67 years
Average BMI: not reported
Interventions Experimental intervention: tidal irrigation and standard conservative care (volume of
irrigation fluid:1,000ml)
Control intervention: standard conservative care
Treatment duration: 12 weeks for standard conservative care
Outcomes Extracted pain outcome: pain after walking 50-foot after 12 weeks
Extracted function outcome: 50-foot walk time (seconds) after 12 weeks
Primary outcome: pain scores (used for power calculation)
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear No information provided
Allocation concealment? Unclear No information provided
Described as double-blind? No
Blinding of patients? No
Blinding of physicians? No
Interventions reported as indistinguish-
able?
No
Double-dummy technique used? No
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Ike 1992 (Continued)
Intention-to-treat analysis (pain)? No 10 of 39 patients excluded in experimental
group; 10of 38patients excluded in control
group
Intention-to-treat analysis (function)? No 10 of 39 patients excluded in experimental
group; 10of 38patients excluded in control
group
Funding by commercial body avoided? No Sponsor: Abbott Laboratories.
Moseley 1996
Methods Randomised controlled trial
3-arm parallel group design
Trial duration: 26 weeks
Simple randomisation
No power calculation reported
Funding by non-profit organisation: not reported
Participants 10 patients with knee OA were randomised
Number of females: 0 of 10 (0%)
Average age: 46 years
Average BMI: not reported
Interventions Experimental intervention: arthroscopic lavage (volume of irrigation fluid: 10,000 ml)
Control intervention: sham arthroscopic lavage
Analgesics allowed
Outcomes Extracted pain outcome: global pain after 13 weeks
Extracted function outcome: 50-foot walk time (seconds) after 13 weeks
Primary outcome: not reported
Notes 1 trial arm (arthroscopic debridement) excluded from review
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear No information provided
Allocation concealment? Yes
Described as double-blind? Yes
Blinding of patients? Yes
Blinding of physicians? No
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Moseley 1996 (Continued)
Interventions reported as indistinguish-
able?
Unclear No information provided
Double-dummy technique used? No
Intention-to-treat analysis (pain)? No 1 of 3 patients excluded in experimental
group; 0 of 5 patients excluded in control
group
Intention-to-treat analysis (function)? No 1 of 3 patients excluded in experimental
group; 0 of 5 patients excluded in control
group
Funding by commercial body avoided? Yes No author or related institution has re-
ceived any financial benefit from research
in this study
Ravaud 1999
Methods Randomised controlled trial
4-arm factorial design
Trial duration: 24 weeks
Randomisation stratified according to centre
Multicentre trial with 16 centres
No power calculation reported
Funding by non-profit organisation: Société Francaise du Rhumatologie; Direction de
la Recherche Clinique
Participants 98 patients with knee OA were randomised
Number of females: 66 of 98 (67%)
Average age: 65 years
Average BMI: 29 kg/m2
Interventions Experimental intervention: non-arthroscopic lavage (volume of irrigation fluid:
1,000ml)
Control intervention: intra-articular placebo injection
49 patients (50%) allocated to intraarticular corticosteroid using a factorial design; no
evidence for an interaction between treatments
Analgesics allowed
Analgesic co-interventions were assessed
Outcomes Extracted pain outcome: pain on activities other than walking after 12 weeks
Extracted function outcome: Lequesne OA index global score after 12 weeks
Primary outcome: percentage change in pain on VAS
Notes
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Ravaud 1999 (Continued)
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes
Allocation concealment? Unclear No information provided
Described as double-blind? No
Blinding of patients? No
Blinding of physicians? No
Interventions reported as indistinguish-
able?
No
Double-dummy technique used? No
Intention-to-treat analysis (pain)? Yes All randomised patients included in the
analysis
Intention-to-treat analysis (function)? Yes All randomised patients included in the
analysis
Funding by commercial body avoided? No Roussel Laboratories provided study drugs
Kalunian 2000
Methods Randomised controlled trial
2-arm parallel group design
Trial duration: 52 weeks
Simple randomisation
Multicentre trial with 4 centres
Power calculation reported
Funding by non-profit organisation: American College of Rheumatology
Participants 90 patients with knee OA were randomised
Number of females: 48 of 90 (53%)
Average age: 59 years
Average BMI: not reported
Interventions Experimental intervention: arthroscopic lavage (volume of irrigation fluid: 3,000 ml)
Control intervention: minimal irrigation arthroscopy (volume of irrigation fluid: 250ml)
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Kalunian 2000 (Continued)
Outcomes Extracted pain outcome: global pain (VAS) after 13 weeks
Extracted function outcome: WOMAC disability subscore after 13 weeks
Primary outcome: WOMAC global score after 12 months
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes
Allocation concealment? Unclear No information provided
Described as double-blind? Yes
Blinding of patients? Yes
Blinding of physicians? No
Interventions reported as indistinguish-
able?
No
Double-dummy technique used? No
Intention-to-treat analysis (pain)? Unclear No information on exclusions available
Intention-to-treat analysis (function)? Unclear No information on exclusions available
Funding by commercial body avoided? No One co-author was affiliated with Eli Lilly
and Company, and the last author was af-
filiated with Genentech, Inc.
Bradley 2002
Methods Randomised controlled trial
2-arm parallel group design
Trial duration: 52 weeks
Randomisation stratified according to K/L grade
Power calculation reported
Funding by non-profit organisation: NIH R01-AR-42165
Participants 180 patients with knee OA were randomised
Number of females: 124 of 180 (69%)
Average age: 56 years
Average BMI: not reported
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Bradley 2002 (Continued)
Interventions Experimental intervention: tidal irrigation (volume of irrigation fluid: 1,000 ml)
Control intervention: sham tidal irrigation
Analgesics allowed
Analgesic co-interventions were assessed
Outcomes Extracted pain outcome: WOMAC pain subscore after 12 weeks
Extracted function outcome: WOMAC disability subscore after 12 weeks
Primary outcome: change in WOMAC pain and function subscores
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear No information provided
Allocation concealment? Yes
Described as double-blind? Yes
Blinding of patients? Yes
Blinding of physicians? No
Interventions reported as indistinguish-
able?
No
Double-dummy technique used? No
Intention-to-treat analysis (pain)? Yes All randomised patients included in the
analysis
Intention-to-treat analysis (function)? Yes All randomised patients included in the
analysis
Funding by commercial body avoided? Yes Funded by non-profit organisation
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Moseley 2002
Methods Randomised controlled trial
3-arm parallel group design
Trial duration: 103 weeks
Randomisation stratified according to OA severity
Power calculation reported
Funding by non-profit organisation: Departement of Veterans Affairs
Participants 180 patients with knee OA were randomised
Number of females: 13 of 180 (7%)
Average age: 52 years
Average BMI: not reported
Interventions Experimental intervention: arthroscopic lavage (volume of irrigation fluid:10,000ml)
Control intervention: sham arthroscopic lavage
Analgesics allowed
Analgesic co-interventions were assessed
Outcomes Extracted pain outcome: knee specific pain scale after 13 weeks
Extracted function outcome: composite disability scores other than WOMAC after 13
weeks
Primary outcome: knee specific pain scale
Notes 1 trial arm (arthroscopic debridement) excluded from review
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear No information provided
Allocation concealment? Yes
Described as double-blind? Yes
Blinding of patients? Yes
Blinding of physicians? No
Interventions reported as indistinguish-
able?
No
Double-dummy technique used? No
Intention-to-treat analysis (pain)? No 2 of 61 patients excluded in experimental
group; 4 of 60 patients excluded in control
group
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Moseley 2002 (Continued)
Intention-to-treat analysis (function)? No 2 of 61 patients excluded in experimental
group; 4 of 60 patients excluded in control
group
Funding by commercial body avoided? Yes Funded by non-profit organisation
BMI: body mass index
OA: osteoarthritis
VAS: visual analogue scale
Characteristics of excluded studies [ordered by study ID]
Arden 2008 Active control intervention (corticosteroid injection)
Chang 1993 Active control intervention (arthroscopic surgery)
Forster 2003 Active control intervention (hyaluronic acid injection)
Frías 2004 Active control intervention (corticosteroid injection)
Gibson 1992 Active control intervention (arthroscopic surgery)
Hempfling 2007 Active control intervention (hyaluronic acid injection)
Hubbard 1996 Active control intervention (arthroscopic surgery)
Jayaram 2006 No randomisation involved
Karkabi 2000 Active control intervention (arthroscopic surgery)
Lennox 1998 Active control intervention (physiotherapy)
Livesley 1991 No randomisation involved
Merchan 1993 Intervention was arthroscopic surgery and not lavage
Smith 2003 Active control intervention (corticosteroid injection)
Vad 2003 No randomisation involved
Ward 1998 Active control intervention (cannula lavage)
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Characteristics of ongoing studies [ordered by study ID]
ISRCTN82192623
Trial name or title ISRCTN82192623
Methods Randomised controlled trial
3-arm parallel group design
Trial duration: not reported
Power calculation reported
Funding by non-profit organisation: The North and South Bank Research and Development Consortium (
UK)
Participants 219 patients with knee OA were anticipated
Number of females: not reported
Average age: not reported
Average BMI: not reported
Interventions Experimental intervention: arthroscopic washout and intra-articular hyaluronan injection combined
Control intervention: intra-articular hyaluronan injection
Analgesics allowed: unknown
Outcomes Extracted pain outcome: not provided
Extracted function outcome: not provided
Primary outcome: not reported
Starting date 01/01/2002
Contact information Mr A Moshen
Orthopaedic Department
Hull Royal Infirmary
Anlaby Road
Hull
HU3 2JZ
United Kingdom
Tel +44 (0)1482 328 541
Email amr.mohsen@hey.nhs.uk
Notes Status at 18 December 2008: Completed
BMI: body mass index
OA: osteoarthritis
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D A T A A N D A N A L Y S E S
Comparison 1. Joint lavage for osteoarthritis of the knee
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain 7 567 Std. Mean Difference (Random, 95% CI) -0.11 [-0.42, 0.21]
1.1 Arthroscopic joint lavage 3 212 Std. Mean Difference (Random, 95% CI) 0.21 [-0.06, 0.48]
1.2 Non-arthroscopic joint
lavage
2 118 Std. Mean Difference (Random, 95% CI) -0.14 [-1.19, 0.91]
1.3 Tidal irrigation 2 237 Std. Mean Difference (Random, 95% CI) -0.36 [-0.79, 0.07]
2 Function 5 540 Std. Mean Difference (Random, 95% CI) -0.10 [-0.30, 0.11]
2.1 Arthroscopic joint lavage 2 205 Std. Mean Difference (Random, 95% CI) 0.01 [-0.26, 0.29]
2.2 Non-arthroscopic joint
lavage
1 98 Std. Mean Difference (Random, 95% CI) -0.43 [-0.84, -0.02]
2.3 Tidal irrigation 2 237 Std. Mean Difference (Random, 95% CI) -0.04 [-0.43, 0.35]
Comparison 2. Any type of lavage versus sham intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain 7 567 Std. Mean Difference (Random, 95% CI) -0.11 [-0.42, 0.21]
1.1 Sham intervention 4 392 Std. Mean Difference (Random, 95% CI) 0.05 [-0.21, 0.32]
1.2 Placebo injection 2 118 Std. Mean Difference (Random, 95% CI) -0.14 [-1.19, 0.91]
1.3 No control intervention 1 57 Std. Mean Difference (Random, 95% CI) -0.64 [-1.17, -0.11]
2 Function 5 540 Std. Mean Difference (Random, 95% CI) -0.10 [-0.30, 0.11]
2.1 Sham intervention 3 385 Std. Mean Difference (Random, 95% CI) -0.08 [-0.28, 0.12]
2.2 Placebo injection 1 98 Std. Mean Difference (Random, 95% CI) -0.43 [-0.84, -0.02]
2.3 No control intervention 1 57 Std. Mean Difference (Random, 95% CI) 0.23 [-0.30, 0.76]
Comparison 3. Joint lavage for osteoarthritis of the knee: 1 year follow up
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain 3 380 Std. Mean Difference (Random, 95% CI) -0.10 [-0.50, 0.29]
2 Function 3 381 Std. Mean Difference (Random, 95% CI) -0.17 [-0.38, 0.03]
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Analysis 1.1. Comparison 1 Joint lavage for osteoarthritis of the knee, Outcome 1 Pain.
Review: Joint lavage for osteoarthritis of the knee
Comparison: 1 Joint lavage for osteoarthritis of the knee
Outcome: 1 Pain
Study or subgroup Experimental Control Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Arthroscopic joint lavage
Moseley 1996 2 5 0.87 (0.88) 2.9 % 0.87 [ -0.85, 2.59 ]
Kalunian 2000 41 49 0.18 (0.21) 17.5 % 0.18 [ -0.23, 0.59 ]
Moseley 2002 59 56 0.2 (0.19) 18.5 % 0.20 [ -0.17, 0.57 ]
Subtotal (95% CI) 38.9 % 0.21 [ -0.06, 0.48 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.59, df = 2 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 1.49 (P = 0.13)
2 Non-arthroscopic joint lavage
Dawes 1987 10 10 0.47 (0.45) 8.4 % 0.47 [ -0.41, 1.35 ]
Ravaud 1999 45 53 -0.61 (0.21) 17.5 % -0.61 [ -1.02, -0.20 ]
Subtotal (95% CI) 25.9 % -0.14 [ -1.19, 0.91 ]
Heterogeneity: Tau2 = 0.46; Chi2 = 4.73, df = 1 (P = 0.03); I2 =79%
Test for overall effect: Z = 0.27 (P = 0.79)
3 Tidal irrigation
Ike 1992 29 28 -0.64 (0.27) 14.6 % -0.64 [ -1.17, -0.11 ]
Bradley 2002 89 91 -0.19 (0.15) 20.5 % -0.19 [ -0.48, 0.10 ]
Subtotal (95% CI) 35.1 % -0.36 [ -0.79, 0.07 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 2.12, df = 1 (P = 0.15); I2 =53%
Test for overall effect: Z = 1.65 (P = 0.099)
Total (95% CI) 100.0 % -0.11 [ -0.42, 0.21 ]
Heterogeneity: Tau2 = 0.10; Chi2 = 17.22, df = 6 (P = 0.01); I2 =65%
Test for overall effect: Z = 0.66 (P = 0.51)
-2 -1 0 1 2
Favours experimental Favours control
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Analysis 1.2. Comparison 1 Joint lavage for osteoarthritis of the knee, Outcome 2 Function.
Review: Joint lavage for osteoarthritis of the knee
Comparison: 1 Joint lavage for osteoarthritis of the knee
Outcome: 2 Function
Study or subgroup Experimental Control Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Arthroscopic joint lavage
Kalunian 2000 41 49 0.13 (0.21) 18.5 % 0.13 [ -0.28, 0.54 ]
Moseley 2002 59 56 -0.08 (0.19) 21.4 % -0.08 [ -0.45, 0.29 ]
Subtotal (95% CI) 39.9 % 0.01 [ -0.26, 0.29 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.55, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 0.10 (P = 0.92)
2 Non-arthroscopic joint lavage
Ravaud 1999 45 53 -0.43 (0.21) 18.5 % -0.43 [ -0.84, -0.02 ]
Subtotal (95% CI) 18.5 % -0.43 [ -0.84, -0.02 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.05 (P = 0.041)
3 Tidal irrigation
Ike 1992 29 28 0.23 (0.27) 12.4 % 0.23 [ -0.30, 0.76 ]
Bradley 2002 89 91 -0.19 (0.15) 29.1 % -0.19 [ -0.48, 0.10 ]
Subtotal (95% CI) 41.6 % -0.04 [ -0.43, 0.35 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 1.85, df = 1 (P = 0.17); I2 =46%
Test for overall effect: Z = 0.20 (P = 0.84)
Total (95% CI) 100.0 % -0.10 [ -0.30, 0.11 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 5.52, df = 4 (P = 0.24); I2 =28%
Test for overall effect: Z = 0.95 (P = 0.34)
-2 -1 0 1 2
Favours experimental Favours control
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Analysis 2.1. Comparison 2 Any type of lavage versus sham intervention, Outcome 1 Pain.
Review: Joint lavage for osteoarthritis of the knee
Comparison: 2 Any type of lavage versus sham intervention
Outcome: 1 Pain
Study or subgroup Experimental Control Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Sham intervention
Moseley 1996 2 5 0.87 (0.88) 2.9 % 0.87 [ -0.85, 2.59 ]
Kalunian 2000 41 49 0.18 (0.21) 17.5 % 0.18 [ -0.23, 0.59 ]
Moseley 2002 59 56 0.2 (0.19) 18.5 % 0.20 [ -0.17, 0.57 ]
Bradley 2002 89 91 -0.19 (0.15) 20.5 % -0.19 [ -0.48, 0.10 ]
Subtotal (95% CI) 59.4 % 0.05 [ -0.21, 0.32 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 4.37, df = 3 (P = 0.22); I2 =31%
Test for overall effect: Z = 0.40 (P = 0.69)
2 Placebo injection
Dawes 1987 10 10 0.47 (0.45) 8.4 % 0.47 [ -0.41, 1.35 ]
Ravaud 1999 45 53 -0.61 (0.21) 17.5 % -0.61 [ -1.02, -0.20 ]
Subtotal (95% CI) 25.9 % -0.14 [ -1.19, 0.91 ]
Heterogeneity: Tau2 = 0.46; Chi2 = 4.73, df = 1 (P = 0.03); I2 =79%
Test for overall effect: Z = 0.27 (P = 0.79)
3 No control intervention
Ike 1992 29 28 -0.64 (0.27) 14.6 % -0.64 [ -1.17, -0.11 ]
Subtotal (95% CI) 14.6 % -0.64 [ -1.17, -0.11 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.37 (P = 0.018)
Total (95% CI) 100.0 % -0.11 [ -0.42, 0.21 ]
Heterogeneity: Tau2 = 0.10; Chi2 = 17.22, df = 6 (P = 0.01); I2 =65%
Test for overall effect: Z = 0.66 (P = 0.51)
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Analysis 2.2. Comparison 2 Any type of lavage versus sham intervention, Outcome 2 Function.
Review: Joint lavage for osteoarthritis of the knee
Comparison: 2 Any type of lavage versus sham intervention
Outcome: 2 Function
Study or subgroup Experimental Control Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Sham intervention
Bradley 2002 89 91 -0.19 (0.15) 29.1 % -0.19 [ -0.48, 0.10 ]
Kalunian 2000 41 49 0.13 (0.21) 18.5 % 0.13 [ -0.28, 0.54 ]
Moseley 2002 59 56 -0.08 (0.19) 21.4 % -0.08 [ -0.45, 0.29 ]
Subtotal (95% CI) 69.0 % -0.08 [ -0.28, 0.12 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.54, df = 2 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 0.79 (P = 0.43)
2 Placebo injection
Ravaud 1999 45 53 -0.43 (0.21) 18.5 % -0.43 [ -0.84, -0.02 ]
Subtotal (95% CI) 18.5 % -0.43 [ -0.84, -0.02 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.05 (P = 0.041)
3 No control intervention
Ike 1992 29 28 0.23 (0.27) 12.4 % 0.23 [ -0.30, 0.76 ]
Subtotal (95% CI) 12.4 % 0.23 [ -0.30, 0.76 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.85 (P = 0.39)
Total (95% CI) 100.0 % -0.10 [ -0.30, 0.11 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 5.52, df = 4 (P = 0.24); I2 =28%
Test for overall effect: Z = 0.95 (P = 0.34)
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Analysis 3.1. Comparison 3 Joint lavage for osteoarthritis of the knee: 1 year follow up, Outcome 1 Pain.
Review: Joint lavage for osteoarthritis of the knee
Comparison: 3 Joint lavage for osteoarthritis of the knee: 1 year follow up
Outcome: 1 Pain
Study or subgroup Experimental Control Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
Kalunian 2000 41 49 -0.23 (0.21) 30.7 % -0.23 [ -0.64, 0.18 ]
Moseley 2002 57 53 0.29 (0.19) 32.6 % 0.29 [ -0.08, 0.66 ]
Bradley 2002 89 91 -0.35 (0.15) 36.7 % -0.35 [ -0.64, -0.06 ]
Total (95% CI) 100.0 % -0.10 [ -0.50, 0.29 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 7.26, df = 2 (P = 0.03); I2 =72%
Test for overall effect: Z = 0.52 (P = 0.60)
-2 -1 0 1 2
Favours experimental Favours control
Analysis 3.2. Comparison 3 Joint lavage for osteoarthritis of the knee: 1 year follow up, Outcome 2 Function.
Review: Joint lavage for osteoarthritis of the knee
Comparison: 3 Joint lavage for osteoarthritis of the knee: 1 year follow up
Outcome: 2 Function
Study or subgroup Experimental Control Std. Mean Difference (SE) Std. Mean Difference Weight Std. Mean Difference
N N IV,Random,95% CI IV,Random,95% CI
Kalunian 2000 41 49 -0.18 (0.21) 23.9 % -0.18 [ -0.59, 0.23 ]
Moseley 2002 57 54 0 (0.19) 29.2 % 0.0 [ -0.37, 0.37 ]
Bradley 2002 89 91 -0.28 (0.15) 46.9 % -0.28 [ -0.57, 0.01 ]
Total (95% CI) 100.0 % -0.17 [ -0.38, 0.03 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.34, df = 2 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 1.70 (P = 0.090)
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A P P E N D I C E S
Appendix 1. Search strategy
OVID MEDLINE OVID EMBASE CINAHL through EBSCOhost
Search terms for design
1. RANDOMIZED CONTROLLED
TRIAL.pt.
2. CONTROLLED CLINICAL
TRIAL.pt.
3. RANDOMIZED CONTROLLED
TRIAL.sh.
4. RANDOM ALLOCATION.sh.
5. DOUBLE BLIND METHOD.sh.
6. SINGLE BLIND METHOD.sh.
7. CLINICAL TRIAL.pt.
8. exp CLINICAL TRIAL/
9. (clin$ adj25 trial$).ti,ab.
10. ((singl$ or doubl$ or trebl$ or tripl$)
adj25 (blind$ or mask$)).ti,ab.
11. PLACEBOS.sh.
12. placebo$.ti,ab.
13. random$.ti,ab.
14. RESEARCH DESIGN.sh.
15. COMPARATIVE STUDY.sh.
16. exp EVALUATION STUDIES/
17. FOLLOW UP STUDIES.sh.
18. PROSPECTIVE STUDIES.sh.
19. (control$ or prospectiv$ or volunteer$)
.ti,ab.
Search terms for design
1. RANDOMIZED CONTROLLED
TRIAL.sh.
2. RANDOMIZATION.sh.
3. Double Blind Procedure.sh.
4. Single Blind Procedure.sh.
5. exp CLINICAL TRIALS/
6. (clin$ adj25 trial$).ti,ab.
7. ((singl$ or doubl$ or trebl$ or tripl$)
adj25 (blind$ or mask$)).ti,ab.
8. PLACEBO.sh.
9. placebo$.ti,ab.
10. random$.ti,ab.
11. METHODOLOGY.sh.
12. COMPARATIVE STUDY.sh.
13. exp EVALUATION STUDIES/
14. follow up.sh.
15. Prospective Study.sh.
16. (control$ or prospectiv$ or volunteer$)
.ti,ab.
Search terms for design
1. (MH “Clinical Trials+”)
2. (MH “Random Assignment”)
3. (MH “Double-Blind Studies”) or (MH
“Single-Blind Studies”)
4. TX (clin$ n25 trial$)
5. TX (sing$ n25 blind$)
6. TX (sing$ n25 mask$)
7. TX (doubl$ n25 blind$)
8. TX (doubl$ n25 mask$)
9. TX (trebl$ n25 blind$)
10. TX (trebl$ n25 mask$)
11. TX (tripl$ n25 blind$)
12. TX (tripl$ n25 mask$)
13. (MH “Placebos”)
14. TX placebo$
15. TX random$
16. (MH “Study Design+”)
17. (MH “Comparative Studies”)
18. (MH “Evaluation Research”)
19. (MH “Prospective Studies+”)
20. TX (control$ or prospectiv$ or volun-
teer$)
21. S1 or S2 or (…….) or S20
Search terms for Osteoarthritis
20. exp osteoarthritis/
21. osteoarthriti$.ti,ab,sh.
22. osteoarthro$.ti,ab,sh.
23. gonarthriti$.ti,ab,sh.
24. gonarthro$.ti,ab,sh.
25. coxarthriti$.ti,ab,sh.
26. coxarthro$.ti,ab,sh.
27. arthros$.ti,ab.
28. arthrot$.ti,ab.
29. ((knee$ or hip$ or joint$) adj3 (pain$
or ach$ or discomfort$)).ti,ab.
30. ((knee$ or hip$ or joint$) adj3 stiff$)
.ti,ab.
Search terms for Osteoarthritis
17. exp osteoarthritis/
18. osteoarthriti$.ti,ab,sh.
19. osteoarthro$.ti,ab,sh.
20. gonarthriti$.ti,ab,sh.
21. gonarthro$.ti,ab,sh.
22. coxarthriti$.ti,ab,sh.
23. coxarthro$.ti,ab,sh.
24. arthros$.ti,ab.
25. arthrot$.ti,ab.
26. ((knee$ or hip$ or joint$) adj3 (pain$
or ach$ or discomfort$)).ti,ab.
27. ((knee$ or hip$ or joint$) adj3 stiff$)
.ti,ab.
Search terms for Osteoarthritis
22. osteoarthriti$
23. (MH “Osteoarthritis”)
24. TX osteoarthro$
25. TX gonarthriti$
26. TX gonarthro$
27. TX coxarthriti$
28. TX coxarthro$
29. TX arthros$
30. TX arthrot$
31. TX knee$ n3 pain$
32. TX hip$ n3 pain$
33. TX joint$ n3 pain$
34. TX knee$ n3 ach$
35. TX hip$ n3 ach$
36. TX joint$ n3 ach$
37. TX knee$ n3 discomfort$
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(Continued)
38. TX hip$ n3 discomfort$
39. TX joint$ n3 discomfort$
40. TX knee$ n3 stiff$
41. TX hip$ n3 stiff$
42. TX joint$ n3 stiff$
43. S22 or S23 or (...) or S42
Search terms for joint lavage
31. (arthroscop$ adj40 debridement).tw.
32. (arthroscop$ adj40 irrigation).tw.
33. (arthroscop$ adj40 lavage).tw.
34. (arthroscop$ adj40 washout).tw.
35. exp arthroscopy/ and (exp debride-
ment/ or exp Irrigation/)
36. (needle$ adj40 debridement).tw.
37. (needle$ adj40 irrigation).tw.
38. (needle$ adj40 lavage).tw.
39. (needle$ adj40 washout).tw.
Search terms for joint lavage
28. (arthroscop$ adj40 debridement).tw.
29. (arthroscop$ adj40 irrigation).tw.
30. (arthroscop$ adj40 lavage).tw.
31. (arthroscop$ adj40 washout).tw.
32. exp arthroscopy/ and (exp debride-
ment/ or exp Irrigation/)
33. (needle$ adj40 debridement).tw.
34. (needle$ adj40 irrigation).tw.
35. (needle$ adj40 lavage).tw.
36. (needle$ adj40 washout).tw.
Search terms for joint lavage
44. TX (arthroscop$ adj40 debridement)
45. TX (arthroscop$ adj40 irrigation)
46. TX (arthroscop$ adj40 lavage)
47. TX (arthroscop$ adj40 washout)
48. MH arthroscopy/ and (MH debride-
ment/ or MH Irrigation/)
49. TX (needle$ adj40 debridement)
50. TX (needle$ adj40 irrigation)
51. TX (needle$ adj40 lavage)
52. TX (needle$ adj40 washout)
53. S44 or S45 or (...) or S52
Combining terms
40. animal/
41. animal/ and human/
42. 40 not 41
43. or/1-19
44. or/20-30
45. or/31-39
46. and/43-45
47. 46 not 42
48. remove duplicates from 47
Combining terms
37. animal/
38. animal/ and human/
39. 37 not 38
40. or/1-16
41. or/17-27
42. or/28-36
43. and/40-42
44. 43 not 39
45. remove duplicates from 44
Combining terms
S21 and S43 and S53
Appendix 2. CENTRAL search strategy
CENTRAL
Search terms for Osteoarthritis
#1. MeSH descriptor Osteoarthritis explode all trees
#2. (osteoarthritis* OR osteoarthro* OR gonarthriti* OR gonarthro* OR coxarthriti* OR coxarthro* OR arthros* OR arthrot* OR
((knee* OR hip* OR joint*) near/3 (pain* OR ach* OR discomfort*)) OR ((knee* OR hip* OR joint*) near/3 stiff*)) in Clinical
Trials
Search terms for Joint Lavage
#3. MeSH descriptor Debridement
#4. MeSH descriptor Irrigation
#5. MeSH descriptor Arthroscopy
#6. (arthroscop* near/40 debridement) OR (arthroscop* near/40 irrigation) OR (arthroscop* near/40 lavage) OR (arthroscop* near/
40 washout) OR (needle* near/40 debridement) OR (needle* near/40 irrigation) OR (needle* near/40 lavage) OR (needle* near/40
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(Continued)
washout) in Clinical Trials
Combining terms
#7. (#1 OR #2)
#8. (#3 OR #4)
#9. (#5 and #8)
#10. (#9 or #6)
#11. (#7 AND #10) in Clinical Trials
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We broadened our inclusion criteria by including also non-arthroscopic lavage trials. We used risk of bias tables to present the
methodological quality of included trials and a summary of findings table to present results.
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